PPARα-dependent Insig2a overexpression inhibits SREBP-1c processing during fasting

[1]  M. White,et al.  Insulin signaling and reduced glucocorticoid receptor activity attenuate postprandial gene expression in liver , 2018, PLoS biology.

[2]  N. Zhang,et al.  The Transcriptional Factor PPARαb Positively Regulates Elovl5 Elongase in Golden Pompano Trachinotus ovatus (Linnaeus 1758) , 2018, Front. Physiol..

[3]  A. Shevchenko,et al.  The Diurnal Timing of Starvation Differently Impacts Murine Hepatic Gene Expression and Lipid Metabolism – A Systems Biology Analysis Using Self-Organizing Maps , 2018, Front. Physiol..

[4]  S. Koo,et al.  Metformin stimulates IGFBP-2 gene expression through PPARalpha in diabetic states , 2016, Scientific Reports.

[5]  D. Hum,et al.  Hepatoprotective effects of the dual peroxisome proliferator‐activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis , 2013, Hepatology.

[6]  H. Stunnenberg,et al.  Genome-Wide Profiling of Liver X Receptor, Retinoid X Receptor, and Peroxisome Proliferator-Activated Receptor α in Mouse Liver Reveals Extensive Sharing of Binding Sites , 2011, Molecular and Cellular Biology.

[7]  S. Young,et al.  Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. , 2011, Cell metabolism.

[8]  F. Gonzalez,et al.  PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver. , 2011, The Journal of nutrition.

[9]  G. Oh,et al.  Peroxisome Proliferator-activated Receptor α Is Responsible for the Up-regulation of Hepatic Glucose-6-phosphatase Gene Expression in Fasting and db/db Mice* , 2010, The Journal of Biological Chemistry.

[10]  A. Nohturfft,et al.  Coordination of lipid metabolism in membrane biogenesis. , 2009, Annual review of cell and developmental biology.

[11]  X. Deng,et al.  Insulin Enhances the Biogenesis of Nuclear Sterol Regulatory Element-binding Protein (SREBP)-1c by Posttranscriptional Down-regulation of Insig-2A and Its Dissociation from SREBP Cleavage-activating Protein (SCAP)·SREBP-1c Complex* , 2009, The Journal of Biological Chemistry.

[12]  Xiaohui Xie,et al.  Genome-wide analysis of SREBP-1 binding in mouse liver chromatin reveals a preference for promoter proximal binding to a new motif , 2009, Proceedings of the National Academy of Sciences.

[13]  K. Eder,et al.  Activation of PPARα and PPARγ reduces triacylglycerol synthesis in rat hepatoma cells by reduction of nuclear SREBP-1 , 2009 .

[14]  K. Eder,et al.  Activation of PPARalpha and PPARgamma reduces triacylglycerol synthesis in rat hepatoma cells by reduction of nuclear SREBP-1. , 2009, European journal of pharmacology.

[15]  Alberto Zambon,et al.  Fibrates and future PPARα agonists in the treatment of cardiovascular disease , 2008, Nature Clinical Practice Cardiovascular Medicine.

[16]  A. Hamsten,et al.  Insulin-induced gene 2 involvement in human adipocyte metabolism and body weight regulation. , 2008, The Journal of clinical endocrinology and metabolism.

[17]  M. Pérez-Carreras,et al.  A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[18]  R. Hammer,et al.  Schoenheimer effect explained--feedback regulation of cholesterol synthesis in mice mediated by Insig proteins. , 2005, The Journal of clinical investigation.

[19]  G. Gibbons,et al.  A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver. , 2005, The Biochemical journal.

[20]  Y. Ahn,et al.  Glucose-stimulated upregulation of GLUT2 gene is mediated by sterol response element-binding protein-1c in the hepatocytes. , 2005, Diabetes.

[21]  I. Leclercq,et al.  Administration of the potent PPARα agonist, Wy‐14,643, reverses nutritional fibrosis and steatohepatitis in mice , 2004, Hepatology.

[22]  R. Hammer,et al.  Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. , 2004, The Journal of clinical investigation.

[23]  J. Goldstein,et al.  Liver-specific mRNA for Insig-2 down-regulated by insulin: Implications for fatty acid synthesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Goldstein,et al.  Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. S. Brown,et al.  Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  W. Wahli,et al.  Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting , 1999 .

[27]  B. Spiegelman,et al.  ADD1/SREBP-1c Is Required in the Activation of Hepatic Lipogenic Gene Expression by Glucose , 1999, Molecular and Cellular Biology.

[28]  W. Wahli,et al.  Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. , 1999, The Journal of clinical investigation.

[29]  W. Wahli,et al.  Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. , 1996, Endocrinology.

[30]  A. Mahfoudi,et al.  Positive regulation of the peroxisomal β‐oxidation pathway by fatty acids through activation of peroxisome proliferator‐activated receptors (PPAR) , 1993, Biology of the cell.

[31]  I. Issemann,et al.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators , 1990, Nature.